Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Genetics and Molecular Research : GMR|October 6, 2016
Biometric analysis of arabica coffee grown in low potassium nutrient solution under greenhouse conditionsW M Moura, Y J B Soares, A T Amaral Júnior, et al.
Chemistry & Biodiversity|November 13, 2010
Comparative larvicidal activity of essential oils from three medicinal plants against Aedes aegypti LFlávia P Freitas, Silvério P Freitas, Gloria C S Lemos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I studyG Frasci, N Panza, P Comella, et al.
The Journal of Biological Chemistry|March 31, 1995
Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)S A Gravina, L Ho, C B Eckman, et al.
Oncology Reports|May 19, 2011
A phase I study of cisplatin, methotrexate, levofolinic acid and 5-fluorouracil in advanced squamous cell carcinoma of the head and neckF Caponigro, P Comella, A Daponte, et al.
Cancer|March 26, 1999
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neckF Caponigro, P Comella, P Marcolin, et al.
American Journal of Clinical Oncology|June 1, 1994
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II studyF Perrone, S De Placido, C Carlomagno, et al.
Cancer|January 3, 2001
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology GroupA Daponte, P A Ascierto, A Gravina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology GroupP Comella, R Casaretti, F De Vita, et al.
Genetics and Molecular Research : GMR|February 15, 2013
Snap bean recommendation based on different methods of phenotypic stabilityC D Marinho, G A Gravina, L C Araújo, et al.
Pageof 7